Compositions and methods for targeted delivery to cells
US-2024390271-A1 · Nov 28, 2024 · US
US8993741B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8993741-B2 |
| Application number | US-201013510149-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 17, 2010 |
| Priority date | Nov 17, 2009 |
| Publication date | Mar 31, 2015 |
| Grant date | Mar 31, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention includes an isolated nucleic acid comprising a nucleic acid sequence encoding a SMNΔ7 degron and the encoded polypeptide. The invention also includes inhibitors of SMNΔ7 degron. The invention also includes compositions and methods for mitigating SMN deficiency by targeting inhibition of factors that mediate SMNΔ7-degron dependent degradation of SMNΔ7.
Opening claim text (preview).
What is claimed: 1. An isolated nucleic acid encoding a chimeric polypeptide comprising a degradation signal sequence and a target sequence, wherein the degradation signal sequence consists of SEQ ID NO. 3 or SEQ ID NO. 14. 2. An isolated nucleic acid consisting of SEQ ID NO. 3 or SEQ ID NO. 14, wherein said nucleic acid is operably linked to sequence of a vector.
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.